XLO XILIO THERAPEUTICS INC Other Situations 8-K Filing 2023 - Press Release Xilio Therapeutics, Inc. issued a press release announcing preliminary data from its ongoing Phase 1/2 clinical trial and outlining plans for potential key milestones across its clinical-stage pipeline, subject to obtaining additional capital.Get access to all SEC 8-K filings of the XILIO THERAPEUTICS INC